A&D Pharma intends to give up the listing from the London Stock Exchange. A decision in this sense will be made at the end of January, according to Mediafax newswire.
The last day of transaction with the company’s shares will be February 28, 2011. A&D Pharma has been listed at the London Stock Exchange since 2006. The company posted EUR 482.2 million in the first nine months of the year, which represented 32 percent growth on the similar period of 2009.
The main shareholder in A&D Pharma is Sograno, with a 59 percent stake, a company registered in The Netherlands. Sograno is owned by Michel Eid, Ludovic Robert, Roger Akoury and Walid Abboud. A stake of 34 percent is transactioned on the capital market and the remaining 7 percent belongs to former CEOs of the company.